MYC and cancer: We also reasoned that loss of the residual PVT1ts in cells with MYC/PVT1 gain + PVT1 translocation, or cells with MYC/PVT1 gain without PVT1 translocation, would further augment MYC expression and contribute to increased aggressiveness in these cancer cells.